Poly-N-acryloyl-(l-phenylalanine methyl ester) hollow core nanocapsules facilitate sustained delivery of immunomodulatory drugs and exhibit adjuvant properties

Abstract

Polymeric hollow nanocapsules have attracted significant research attention as novel drug carriers and their preparation is of particular concern owing to the feasibility to encapsulate a broad range of drug molecules. This work presents for the first time the synthesis and development of novel poly-N-acryloyl l-phenylalanine methyl ester hollow core nanocapsules (NAPA-HPNs) of avg. size ca. 100-150 nm by the mini-emulsion technique. NAPA-HPNs are biocompatible and capable of encapsulating sodium nitroprusside (SNP) at a rate of ∼1.3 μM per mg of capsules. These NAPA-HPNs + SNP nano-formulations maintained homeostasis of macrophages which carry and facilitate the action of various drug molecules used against various diseases. These NAPA-HPNs also facilitate the prolonged release of a low level of nitric oxide (NO) and enhance the metabolic activities of pro-inflammatory macrophages, which are important for the action of various drugs in body fluids. NAPA-HPN mediated skewing of naïve macrophages toward the M1 phenotype potentially demonstrates its adjuvant action on the innate immune system. These results potentially suggested that NAPA-HPNs can serve both as a carrier of drugs as well as an adjuvant for the immune system. Thus, these nanocapsules could be used for the effective management of various infectious or tumor diseases where immune-stimulation is paramount for treatment.

PEGylated hollow pH‐responsive polymeric nanocapsules for controlled drug delivery

“…Polymeric hollow nanocapsules (HNCaps) represent one of the valuable advances and innovative achievements in the field of nanomedicine . These types of NPs consist of a hollow inner core surrounded by a polymeric shell, and have received a great deal of attention mainly due to their potential biomedical applications, including as drug or gene delivery vehicles, nanoreactors and protective shells for enzymes . In the case of DDSs, HNCaps exhibit excellent capability for encapsulation of large quantities of guest molecules (e.g.…”

<p>O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying</p>

“…16 Particle size, the polydispersity index (PDI) and carrying mode are considered to be key factors that influence the nanoemulsion adjuvant effect. [17][18][19] Additionally, the aqueous phase and oil phase play an important role in nanoemulsion formation. [20][21][22] In our research, different NEs are mixed with an H3N2 vaccine, and their adjuvant effects in a mouse model are considered, to explore how these parameters change the immune response intensity, aiming to choose the best formulation for further application.…”

Effective in vitro delivery of paclitaxel by nanocargo of mesoporous polycaprolactone against triple negative breast cancer cells by minimalizing drug dose

“…Therefore, continuous efforts are being made in this eld to improve the therapeutic efficiency of drugs carrying fewer side effects. [6][7][8] The biodegradable 'polymer based nano-sized capsules' are becoming more promising as a drug delivery cargo [9][10][11][12][13] because of their advantages over the other nanomaterials used for delivery applications. 14 The polymer nanocapsules are engineered by encapsulating the drugs or other biomolecules on the surface or inside of the nanoparticle by chemical or physical approaches.…”